Bloomberg Markets & Finance via Youtube


Oct.15 — Roche Holding AG Chief Executive Officer Severin Schwan discusses the antibody cocktail that the Swiss drugmaker is developing with Regeneron Pharmaceuticals Inc. to treat Covid-19. He speaks from Basel, Switzerland, on “Bloomberg Markets: European Open” after Roche’s third-quarter sales fell short of estimates.

READ ALSO  SE: SoftBank Stock Trading Unit Said to Amass Over $20 Billion